1. Home
  2. STVN vs FCN Comparison

STVN vs FCN Comparison

Compare STVN & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • FCN
  • Stock Information
  • Founded
  • STVN 1949
  • FCN 1982
  • Country
  • STVN Italy
  • FCN United States
  • Employees
  • STVN N/A
  • FCN N/A
  • Industry
  • STVN Containers/Packaging
  • FCN Professional Services
  • Sector
  • STVN Consumer Discretionary
  • FCN Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • FCN Nasdaq
  • Market Cap
  • STVN 5.7B
  • FCN 5.9B
  • IPO Year
  • STVN 2021
  • FCN 1996
  • Fundamental
  • Price
  • STVN $21.77
  • FCN $164.93
  • Analyst Decision
  • STVN Buy
  • FCN Hold
  • Analyst Count
  • STVN 6
  • FCN 2
  • Target Price
  • STVN $25.08
  • FCN $175.50
  • AVG Volume (30 Days)
  • STVN 338.6K
  • FCN 414.8K
  • Earning Date
  • STVN 05-08-2025
  • FCN 04-24-2025
  • Dividend Yield
  • STVN 0.27%
  • FCN N/A
  • EPS Growth
  • STVN N/A
  • FCN 1.30
  • EPS
  • STVN 0.45
  • FCN 7.81
  • Revenue
  • STVN $1,143,012,735.00
  • FCN $3,698,652,000.00
  • Revenue This Year
  • STVN $8.60
  • FCN $1.36
  • Revenue Next Year
  • STVN $10.43
  • FCN $6.38
  • P/E Ratio
  • STVN $48.77
  • FCN $21.45
  • Revenue Growth
  • STVN 1.72
  • FCN 6.00
  • 52 Week Low
  • STVN $16.56
  • FCN $151.75
  • 52 Week High
  • STVN $28.77
  • FCN $243.60
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.72
  • FCN 56.03
  • Support Level
  • STVN $21.13
  • FCN $163.01
  • Resistance Level
  • STVN $22.46
  • FCN $166.29
  • Average True Range (ATR)
  • STVN 1.33
  • FCN 4.68
  • MACD
  • STVN 0.12
  • FCN 1.27
  • Stochastic Oscillator
  • STVN 86.32
  • FCN 78.87

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: